Biohit Oyj (HEL:BIOBV)

Biohit Oyj Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	15.7	14.28	13.08	10.95	9.36
Revenue Growth (YoY)	9.92%	9.23%	19.41%	16.98%	31.42%
Cost of Revenue	4.9	4.94	4.61	3.84	3.45
Gross Profit	10.8	9.34	8.46	7.11	5.92
Selling, General & Admin	4.2	4	4.09	3.63	3.45
Other Operating Expenses	3.1	2.44	2.19	1.87	1.98
Operating Expenses	7.8	6.78	6.64	5.98	7.42
Operating Income	3	2.56	1.83	1.13	-1.5
Interest Expense	-0.1	-	-	-	-
Interest & Investment Income	0.1	-	-	-	-
Currency Exchange Gain (Loss)	-	-	0.03	-0.01	0.02
Other Non Operating Income (Expenses)	-0.1	0.56	0.41	-0.29	0.09
EBT Excluding Unusual Items	2.9	3.12	2.26	0.83	-1.39
Gain (Loss) on Sale of Investments	-	-0.25	-0.07	0.04	0.06
Gain (Loss) on Sale of Assets	-	-	-	-	0.02
Pretax Income	2.9	2.87	2.2	0.87	-1.31
Income Tax Expense	0.2	0.3	0.34	0.27	0.2
Net Income	2.7	2.57	1.85	0.6	-1.5
Net Income to Common	2.7	2.57	1.85	0.6	-1.5
Net Income Growth	5.14%	38.74%	207.99%	-	-
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	15	15	15	15
Shares Change (YoY)	-0.18%	0.58%	0.41%	0.13%	-
EPS (Basic)	0.18	0.17	0.12	0.04	-0.10
EPS (Diluted)	0.18	0.17	0.12	0.04	-0.10
EPS Growth	4.96%	41.15%	200.41%	-	-
Free Cash Flow	-1.3	0.18	0.65	1.79	-0.48
Free Cash Flow Per Share	-0.09	0.01	0.04	0.12	-0.03
Gross Margin	68.79%	65.39%	64.73%	64.94%	63.19%
Operating Margin	19.11%	17.90%	13.96%	10.30%	-16.02%
Profit Margin	17.20%	17.98%	14.16%	5.49%	-16.02%
Free Cash Flow Margin	-8.28%	1.29%	5.00%	16.34%	-5.10%
EBITDA	3.5	2.62	1.93	1.34	0.23
EBITDA Margin	22.29%	18.34%	14.78%	12.24%	2.46%
D&A For EBITDA	0.5	0.06	0.11	0.21	1.73
EBIT	3	2.56	1.83	1.13	-1.5
EBIT Margin	19.11%	17.90%	13.96%	10.30%	-16.02%
Effective Tax Rate	6.90%	10.43%	15.67%	30.76%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.